Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The type of anti-inflammatory medication used post selective laser trabeculoplasty (SLT) may have an impact on the intra-ocular pressure (IOP) lowering effect of SLT. This study will evaluate the IOP lowering effect of SLT following the topical administration of one of the following: prednisolone 1%, ketorolac 0.5% or artificial tears.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Queen's University
• Collaborators: Glaucoma Research Society of Canada; Pfizer
• Treatments: Anti-Inflammatory Agents; Ketorolac; Ketorolac Tromethamine; Lubricant Eye Drops; Methylprednisolone; Methylprednisolone acetate; Methylprednisolone Hemisuccinate; Ophthalmic Solutions; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate; Tetrahydrozoline

Criteria

Inclusion Criteria:

• primary open angle glaucoma, pseudo exfoliation glaucoma

Exclusion Criteria:

• previous incisional glaucoma surgery